Blog

Frameshift has been awarded a Phase I STTR in collaboration with the Marth Laboratory at the University of Utah to improve the speed of the gene.iobio tool. As part of this development, gene.iobio will be more tightly integrated with Mosaic to provide a seamless variant interrogation platform.

A beta release of Mosaic serving the Undiagnosed Diseases Network (UDN) data has been released for testing.

The clin.iobio diagnostic workflow tool has been published as part of a Special Issue on Precision Medicine in Clinical Practice. This tool is available for use in Mosaic.

We are proud to announce that the gene.iobio paper has been published in Nature Scientific Reports. This tool has been developed at the University of Utah, with significant contribution from Frameshift co-founders.

The Mosaic platform continues to grow, with new features and analysis capabilities to support genomic data projects. We recently made some big upgrades to Mosaic's data visualizations that make exploring your data far more rewarding.

We are excited to announce the development of a visual genomic data portal to support the University of Utah.

Mosaic lets users upload as many genomic samples (BAM, VCF) as you like. Here is how we manage that without incurring prohbitively huge costs.

In this blog post I will go over 2 areas during the genomic analysis/investigation where visualization can have a significant impact.

Frameshift Labs is now in collaboration with the Simons Foundation Autism Research Initiative.

Frameshift Labs is now in collaboration with the Simons Foundation Autism Research Initiative.

Frameshift Genomics has been awarded a Phase II SBIR grant from NHGRI to pursue development of a genomic data management and exploration platform.

Frameshift Genomics has recently been awarded two grants from the NHGRI, a phase I STTR and a phase I SBIR. In collaboration with the Marth Lab at the University of Utah, these grants aim to improve the IOBIO real-time genomic visualization and analysis project.

Frameshift Genomics has been accepted into the NIH I-Corps accelerator, which is an 8 week accelerator, providing SBIR/STTR awardees with access to a team of bio-tech entrepreneurial experts with proven track records.

Frameshift Genomics has been awarded a STTR with the Marth Lab to improve IOBIO - a real-time genomic visualization and analysis project.